-The Economic Times Grain stocks with state agencies are likely to cross 75 million tonnes some time in June 2012, while covered capacity to store is less than 50 million tonnes. The rest would be under CAP (with pucca or even kachcha plinths) exposed to potential large-scale damage. An early and rational policy decision is required to reduce the stocks by at least 7-10 million tonnes to avoid high costs of...
More »SEARCH RESULT
Business proving disastrous in policy on food & agriculture
-The Economic Times Ashok Gulati, chairman of the Commission for Agricultural Costs and Prices, warns that India will have a record food grain stock of 75 million tonnes by June when wheat procurement for the year would be over. A third of it would be stored in the open, and vulnerable to damage from rain, as covered storage capacity is only 50 million tonnes. If these stocks are not run down...
More »Gujarat riots: 'So what if words were spoken within 4 walls?'
-Express News Service The Supreme Court appointed Special Investigation Team (SIT) has concluded that even if Narendra Modi gave an illegal verbal instruction to allow Hindus to “vent their anger” after the Godhra carnage, it was not an offence. “...The interpretations made on alleged illegal instructions given by the Chief Minister by (police officers) Shri R B Sreekumar and Shri Sanjiv Bhatt, appear to be without any basis. Further, even if such...
More »Supreme Court notice to food authority on checking supply of adulterated milk -Savvy Soumya Misra
Petition seeks comprehensive policy on production, supply and sale of healthy, hygienic and natural milk The Supreme Court on May 9 sought a response from the apex food body, the Food Safety and Standards Authority of India (FSSAI), and the states regarding milk adulteration and production of synthetic milk. The three-judge bench sought their response on the public interest petition filed by Swami Achyutanand Tirth on behalf of the Swami Bhumanand...
More »Panel exposes flaws in India’s drug approval procedure-Vidya Krishnan
A report by a parliamentary committee has shown that the drug industry regulator, the Drug Controller General of India (DCGI), has been approving, on average, one new drug a month without conducting mandatory clinical trials or seeking expert medical opinion—findings that expose the deep flaws prevalent in India’s drug approval process. The committee has asked the health ministry to withdraw the discretionary powers given to the Central Drugs Standard Control Organization...
More »